McDermott M L, Swendris R P, Shin D H, Juzych M S, Cowden J W
Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan 48201.
Am J Ophthalmol. 1993 Jan;115(1):93-6. doi: 10.1016/s0002-9394(14)73530-5.
Implantation of a Molteno drainage shunt has been shown to be effective in advanced glaucoma. Foreign substances within the anterior chamber have been known to cause progressive endothelial cell loss. We undertook a study to evaluate the endothelial effects of an indwelling Molteno drainage shunt. Nineteen patients who underwent uneventful implantation of a Molteno drainage shunt for advanced aphakic or pseudophakic glaucoma were followed up. Serial endothelial cell counts were obtained in a masked fashion. During follow-up periods ranging from 5.4 to 25.7 months, endothelial cell loss averaged two cells per square millimeter per postoperative month with a 95% confidence interval of positive seven cells to negative ten cells per square millimeter per postoperative month. No clinically significant progressive trend in endothelial cell loss was seen in patients undergoing uncomplicated Molteno drainage procedures. Larger sample sizes with longer follow-up will be necessary to establish whether a Molteno drainage shunt causes clinically remarkable endothelial cell loss.
已证明植入莫尔滕诺引流分流管对晚期青光眼有效。已知前房内的异物会导致内皮细胞逐渐丢失。我们进行了一项研究,以评估留置莫尔滕诺引流分流管对内皮细胞的影响。对19例因晚期无晶状体或人工晶状体性青光眼而顺利植入莫尔滕诺引流分流管的患者进行了随访。以盲法获得连续的内皮细胞计数。在5.4至25.7个月的随访期内,内皮细胞丢失平均为术后每月每平方毫米两个细胞,95%置信区间为术后每月每平方毫米正七个细胞至负十个细胞。在接受无并发症莫尔滕诺引流手术的患者中,未观察到内皮细胞丢失有临床上显著的进展趋势。需要更大的样本量和更长的随访时间来确定莫尔滕诺引流分流管是否会导致临床上显著的内皮细胞丢失。